COVID-19 Diagnostics Market Size, Share, Trends, Growth and Forecast 2026

COVID-19 Diagnostics Market

COVID-19 Diagnostics Market By Product (Instruments, Kits & Reagents, Diagnostic Services), By Technology (Molecular assay, Immunological assay, Digital PCR (dPCR), Clustered regularly interspaced short palindromic repeats (CRISPR), Microarray), By Test Type (Antigen-based Testing, Antibody (Serology) Testing, Molecular (PCR) Testing, Others) By Mode (Point-of-Care (PoC), Non-Point-of-Care (Non-PoC) By End-User (Hospitals, Diagnostic Labs & Clinics, Healthcare Labs & Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5323 Published Date: Mar-2020 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 52.56 Billion USD 145.48 Billion 15.65% 2019

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global COVID-19 Diagnostics Market, 2016 – 2026 (USD Billion)
    • 3.2.Global COVID-19 Diagnostics Market: Snapshot
  • Chapter 4.COVID-19 Diagnostics Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
    • 4.3.Market Restraints
    • 4.4.Market Opportunities
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global COVID-19 Diagnostics Market Attractiveness, By Product
    • 5.2.Global COVID-19 Diagnostics Market Attractiveness, By Technology
    • 5.3.Global COVID-19 Diagnostics Market Attractiveness, By Test Type
    • 5.4.Global COVID-19 Diagnostics Market Attractiveness, By Mode
    • 5.5.Global COVID-19 Diagnostics Market Attractiveness, By End-User
    • 5.6.Global COVID-19 Diagnostics Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global COVID-19 Diagnostics Market: Company Market Share, 2019
    • 6.2.Strategic Developments
  • Chapter 7.COVID-19 Diagnostics Market – Product Segment Analysis
    • 7.1.Global COVID-19 Diagnostics Market Overview: by Product
      • 7.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Product, 2019 & 2026
    • 7.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Product
      • 7.2.1.Instruments – Overview/Analysis
      • 7.2.2.Kits & Reagents – Overview/Analysis
      • 7.2.3.Diagnostic Services– Overview/Analysis
    • 7.3.Instruments
      • 7.3.1.Global COVID-19 Diagnostics Market for Instruments, Revenue (USD Billion) 2016 - 2026
    • 7.4.Kits & Reagents
      • 7.4.1.Global COVID-19 Diagnostics Market for Kits & Reagents, Revenue (USD Billion) 2016 – 2026
    • 7.5.Diagnostic Services
      • 7.5.1.Global COVID-19 Diagnostics Market for Diagnostic Services, Revenue (USD Billion) 2016 – 2026
  • Chapter 8.COVID-19 Diagnostics Market – Technology Segment Analysis
    • 8.1.Global COVID-19 Diagnostics Market Overview: by Technology
      • 8.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Technology, 2019 & 2026
    • 8.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Technology
      • 8.2.1.Mulecular assay – Overview/Analysis
      • 8.2.2.Immunulogical assay – Overview/Analysis
      • 8.2.3.Digital PCR (dPCR) – Overview/Analysis
      • 8.2.4.Clustered regularly interspaced short palindromic repeats (CRISPR) – Overview/Analysis
      • 8.2.5.Microarray– Overview/Analysis
    • 8.3.Mulecular assay
      • 8.3.1.Global COVID-19 Diagnostics Market for Mulecular assay, Revenue (USD Billion) 2016 - 2026
    • 8.4.Immunulogical assay
      • 8.4.1.Global COVID-19 Diagnostics Market for Immunulogical assay, Revenue (USD Billion) 2016 - 2026
    • 8.5.Digital PCR (dPCR)
      • 8.5.1.Global COVID-19 Diagnostics Market for Digital PCR (dPCR), Revenue (USD Billion) 2016 - 2026
    • 8.6.Clustered regularly interspaced short palindromic repeats (CRISPR)
      • 8.6.1.Global COVID-19 Diagnostics Market for Clustered regularly interspaced short palindromic repeats (CRISPR), Revenue (USD Billion) 2016 - 2026
    • 8.7.Microarray
      • 8.7.1.Global COVID-19 Diagnostics Market for Microarray, Revenue (USD Billion) 2016 - 2026
  • Chapter 9.COVID-19 Diagnostics Market – Test Type Segment Analysis
    • 9.1.Global COVID-19 Diagnostics Market Overview: by Test Type
      • 9.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Test Type, 2019 & 2026
    • 9.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Test Type
      • 9.2.1.Antigen-based Testing – Overview/Analysis
      • 9.2.2.Antibody (Serulogy) Testing – Overview/Analysis
      • 9.2.1.Mulecular (PCR) Testing– Overview/Analysis
      • 9.2.2.Others– Overview/Analysis
    • 9.3.Antigen-based Testing
      • 9.3.1.Global COVID-19 Diagnostics Market for Antigen-based Testing, Revenue (USD Billion) 2016 - 2026
    • 9.4.Antibody (Serulogy) Testing
      • 9.4.1.Global COVID-19 Diagnostics Market for Antibody (Serulogy) Testing, Revenue (USD Billion) 2016 - 2026
    • 9.5.Mulecular (PCR) Testing
      • 9.5.1.Global COVID-19 Diagnostics Market for Mulecular (PCR) Testing, Revenue (USD Billion) 2016 – 2026
    • 9.5.Others
      • 9.5.1.Global COVID-19 Diagnostics Market for Others, Revenue (USD Billion) 2016 – 2026
  • Chapter 10.COVID-19 Diagnostics Market – Mode Segment Analysis
    • 10.1.Global COVID-19 Diagnostics Market Overview: by Mode
      • 10.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Mode, 2019 & 2026
    • 10.2.Global COVID-19 Diagnostics Market Analysis/Overview – By Mode
      • 10.2.1.Point-of-Care (PoC) – Overview/Analysis
      • 10.2.2.Non-Point-of-Care (Non-PoC)– Overview/Analysis
    • 10.3.Point-of-Care (PoC)
      • 10.3.1.Global COVID-19 Diagnostics Market for Point-of-Care (PoC), Revenue (USD Billion) 2016 - 2026
    • 10.4.Non-PoC
      • 10.4.1.Global COVID-19 Diagnostics Market for Non-PoC, Revenue (USD Billion) 2016 - 2026
  • Chapter 11.COVID-19 Diagnostics Market – End User Segment Analysis
    • 11.1.Global COVID-19 Diagnostics Market Overview: by End User
      • 11.1.1.Global COVID-19 Diagnostics Market Revenue Share, by End User, 2019 & 2026
    • 11.2.Global COVID-19 Diagnostics Market Analysis/Overview – By End User
      • 11.2.1.Hospitals – Overview/Analysis
      • 11.2.2.Diagnostic Labs & Clinics– Overview/Analysis
      • 11.2.1.Healthcare Labs & Clinics– Overview/Analysis
    • 11.3.Hospitals
      • 11.3.1.Global COVID-19 Diagnostics Market for Hospitals, Revenue (USD Billion) 2016 - 2026
    • 11.4.Diagnostic Labs & Clinics
      • 11.4.1.Global COVID-19 Diagnostics Market for Diagnostic Labs & Clinics, Revenue (USD Billion) 2016 - 2026
    • 11.5.Mulecular (PCR) Testing
      • 11.5.1.Global COVID-19 Diagnostics Market for Mulecular (PCR) Testing, Revenue (USD Billion) 2016 – 2026
    • 11.5.Healthcare Labs & Clinics
      • 11.5.1.Global COVID-19 Diagnostics Market for Healthcare Labs & Clinics, Revenue (USD Billion) 2016 – 2026
  • Chapter 12.COVID-19 Diagnostics Market – Regional Analysis
    • 12.1.Global COVID-19 Diagnostics Market: Regional Overview
      • 12.1.1.Global COVID-19 Diagnostics Market Revenue Share, by Region, 2019 & 2026
      • 12.1.2.Global COVID-19 Diagnostics Market Revenue, by Region, 2016 – 2026 (USD Billion)
    • 12.2.North America
      • 12.2.1.North America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.2.2.North America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.2.3.North America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.2.4.North America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.2.5.North America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.2.6.North America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.2.7.North America COVID-19 Diagnostics Market Revenue, by End User, 2016 – 2026
      • 12.2.8. U.S.
      • 12.2.9.Canada
    • 12.3.Europe
      • 12.3.1.Europe COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.3.2.Europe COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.3.3.Europe COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.3.4.Europe COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.3.5.Europe COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.3.6.Europe COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.3.7.Europe COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
      • 12.3.8.Germany
      • 12.3.9.France
      • 12.3.10. U.K.
      • 12.3.11.Rest of Europe
    • 12.4.Asia Pacific
      • 12.4.1.Asia Pacific COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.4.2.Asia Pacific COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.4.3.Asia Pacific COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.4.4.Asia Pacific COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.4.5.Asia Pacific COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.4.6.Asia Pacific COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.4.7.Asia Pacific COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
      • 12.4.8.China
      • 12.4.9.Japan
      • 12.4.10.India
      • 12.4.11.Rest of Asia Pacific
    • 12.5.Latin America
      • 12.5.1.Latin America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.5.2.Latin America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.5.3.Latin America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.5.4.Latin America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.5.5.Latin America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.5.6.Latin America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.5.7.Latin America COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
      • 12.5.8.Brazil
      • 12.5.9.Mexico
      • 12.5.10.Rest of Latin America
    • 12.6.The Middle-East and Africa
      • 12.6.1.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
      • 12.6.2.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 12.6.3.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026
      • 12.6.4.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026
      • 12.6.5.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026
      • 12.6.6.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026
      • 12.6.7.The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026
  • Chapter 13.Company Profiles
    • 13.1.Aspen Pharmacare Hulding, Ltd.
    • 13.2.Hulogic Inc.
    • 13.3.Perkin Elmer, Inc.
    • 13.4.Veredus Laboratories
    • 13.5.Thermo Fisher Scientific, Inc.
    • 13.6. F. Hoffman-La Roche Ltd.
    • 13.7.1drop Inc.
    • 13.8.Laboratory Corporation of America Huldings
    • 13.9.ADT Biotech Sdn Bhd
    • 13.1. bioMérieux SA
    • 13.11.Neuberg Diagnostics
    • 13.12.Luminex Corporation
    • 13.13.Quidel Corporation
    • 13.14.ALDATU BIOSCIENCES
    • 13.15.Danaher
    • 13.16.Mylab Discovery Sulutions Pvt. Ltd.
    • 13.17.Quest Diagnostics
    • 13.18.altona Diagnostics GmbH
    • 13.19.Abbott

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 5 Porter’s Five Forces Analysis for Global COVID-19 Diagnostics Market
FIG. 6 Global COVID-19 Diagnostics Market Attractiveness, By Product
FIG. 7 Global COVID-19 Diagnostics Market Attractiveness, By Technology
FIG. 8 Global COVID-19 Diagnostics Market Attractiveness, By Test Type
FIG. 9 Global COVID-19 Diagnostics Market Attractiveness, By Mode
FIG. 10 Global COVID-19 Diagnostics Market Attractiveness, By End-User
FIG. 11 Global COVID-19 Diagnostics Market Attractiveness, By Region
FIG. 12 Company Share Analysis, 2019
FIG. 13 Global COVID-19 Diagnostics Market Revenue Share, by Product, 2019 & 2026
FIG. 14 Global COVID-19 Diagnostics Market for Instruments, Revenue (USD Billion) 2016 - 2026
FIG. 15 Global COVID-19 Diagnostics Market for Kits & Reagents, Revenue (USD Billion) 2016 – 2026
FIG. 16 Global COVID-19 Diagnostics Market for Diagnostic Services, Revenue (USD Billion) 2016 - 2026
FIG. 17 Global COVID-19 Diagnostics Market Revenue Share, by Technology, 2019 & 2026
FIG. 18 Global COVID-19 Diagnostics Market for Molecular assay, Revenue (USD Billion) 2016 - 2026
FIG. 19 Global COVID-19 Diagnostics Market for Immunological assay, Revenue (USD Billion) 2016 - 2026
FIG. 20 Global COVID-19 Diagnostics Market for Digital PCR (dPCR), Revenue (USD Billion) 2016 – 2026
FIG. 21 Global COVID-19 Diagnostics Market for Clustered regularly interspaced short palindromic repeats (CRISPR), Revenue (USD Billion) 2016 – 2026
FIG. 22 Global COVID-19 Diagnostics Market for Microarray, Revenue (USD Billion) 2016 – 2026
FIG. 23 Global COVID-19 Diagnostics Market Revenue Share, by Test Type, 2019 & 2026
FIG. 24 Global COVID-19 Diagnostics Market for Antigen-based Testing, Revenue (USD Billion) 2016 - 2026
FIG. 25 Global COVID-19 Diagnostics Market for Antibody (Serology) Testing, Revenue (USD Billion) 2016 – 2026
FIG. 26 Global COVID-19 Diagnostics Market for Molecular (PCR) Testing, Revenue (USD Billion) 2016 – 2026
FIG. 27 Global COVID-19 Diagnostics Market for Others, Revenue (USD Billion) 2016 – 2026
FIG. 28 Global COVID-19 Diagnostics Market Revenue Share, by Mode, 2019 & 2026
FIG. 29 Global COVID-19 Diagnostics Market for Point-of-Care (PoC), Revenue (USD Billion) 2016 - 2026
FIG. 30 Global COVID-19 Diagnostics Market for Non-Point-of-Care (Non-PoC), Revenue (USD Billion) 2016 – 2026
FIG. 31 Global COVID-19 Diagnostics Market Revenue Share, by End-User, 2019 & 2026
FIG. 32 Global COVID-19 Diagnostics Market for Hospitals, Revenue (USD Billion) 2016 - 2026
FIG. 33 Global COVID-19 Diagnostics Market for Diagnostic Labs & Clinics, Revenue (USD Billion) 2016 – 2026
FIG. 34 Global COVID-19 Diagnostics Market for Healthcare Labs & Clinics, Revenue (USD Billion) 2016 - 2026
FIG. 35 Global COVID-19 Diagnostics Market Revenue Share, by Region, 2019 & 2026
FIG. 36 North America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 37 Europe COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 38 Asia Pacific COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 39 Latin America COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
FIG. 40 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, 2016 - 2026 (USD Billion)
 


Table Of Tables

List of Tables

TABLE 1 Global COVID-19 Diagnostics Market: Snapshot
TABLE 2 Drivers of the COVID-19 Diagnostics Market: Impact Analysis
TABLE 3 Restraints for the COVID-19 Diagnostics Market: Impact Analysis
TABLE 4 Global COVID-19 Diagnostics Market Revenue, by Region, 2016 – 2026 (USD Billion)
TABLE 5 North America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 6 North America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 7 North America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 8 North America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 9 North America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 10 North America COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 11 Europe COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 12 Europe COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 13 Europe COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 14 Europe COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 15 Europe COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 16 Europe COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 17 Asia Pacific COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 18 Asia Pacific COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 19 Asia Pacific COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 20 Asia Pacific COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 21 Asia Pacific COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 22 Asia Pacific COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 23 Latin America COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 24 Latin America COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 25 Latin America COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 26 Latin America COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 27 Latin America COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 28 Latin America COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)
TABLE 29 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 30 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Product, 2016 – 2026 (USD Billion)
TABLE 31 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Technology, 2016 – 2026 (USD Billion)
TABLE 32 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Test Type, 2016 – 2026 (USD Billion)
TABLE 33 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by Mode, 2016 – 2026 (USD Billion)
TABLE 34 The Middle-East and Africa COVID-19 Diagnostics Market Revenue, by End-User, 2016 – 2026 (USD Billion)

Methodology

FrequentlyAsked Questions

With the growing number of coronavirus-infected patients, the demand for COVID-19 diagnostic products is set to raise, particularly after the ease of lockdown across the globe. According to worldometer, as of January 06, 2021, the total number of coronavirus cases worldwide has risen to 86,999,323 with 1,879,435 death cases and 61,691,561 recoveries. Despite the gradual decrease anticipated in the number of positive patients in 2021, market growth is expected to be sustained by incorporating COVID-19 tests into routine diagnostic protocols.

According to Zion Market Research, the COVID-19 Diagnostics market is expected to generate revenue of around USD 12.56 Billion in 2019 and is expected to reach USD 145.48 Billion by 2026, growing at a CAGR of 15.65%.

North America, with a majority of shares in 2020, dominated the market. This can be due to the rapid increase in cases of COVID-19 and the local involvement of key players involved in the development and production of diagnostic tests that combine different technologies. Due to the pandemic, regulatory bodies like the U.S. FDA and Health Canada are granting COVID-19 test kits with Emergency Use Authorizations (EUA) to improve testing. All these factors are expected to drive regional market growth. Asia Pacific is expected to emerge as a lucrative regional market and is projected to grow from 2021 to 2026 at the fastest CAGR. China and India have made important contributions to this region's income. China is a major exporter of COVID-19 test kits, with these kits being exported by more than 100 Chinese companies.

Some of the key players in COVID-19 Diagnostics market are Hologic Inc., Perkin Elmer, Inc., Veredus Laboratories, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., 1drop Inc., Laboratory Corporation of America Holdings, ADT Biotech Sdn Bhd, bioMérieux SA, Neuberg Diagnostics, Luminex Corporation, Quidel Corporation, ALDATU BIOSCIENCES, Danaher, Mylab Discovery Solutions Pvt. Ltd., Quest Diagnostics, altona Diagnostics GmbH and Abbott among others.

Choose License Type

  • zion payment modes

List of Contents

OverviewGrowth FactorsGlobalCOVID-19 DiagnosticsSegmentationGlobalCOVID-19 DiagnosticsMarket:Regional AnalysisReport Scope :GlobalCOVID-19 DiagnosticsCompetitive PlayersGlobalCOVID-19 DiagnosticsRegional Segment Analysis

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed